Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Agile Therapeutics Inc. AGRX

Alternate Symbol(s):  AGXRW

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.


Recent & Breaking News (NDAQ:AGRX)

Agile Therapeutics, Inc. Announces that Twirla® Meets Primary Endpoint in Comparative Wear Study and Demonstrates Non-Inferior Adhesion to Xulane®

GlobeNewswire February 11, 2019

The Daily Biotech Pulse: Agile Gives Regulatory Update On Contraceptive Patch, Advaxis Misses Estimates, Ocular Submits sNDA

Benzinga.com  January 11, 2019

Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance

GlobeNewswire January 10, 2019

Factors of Influence in 2019, Key Indicators and Opportunity within Halozyme Therapeutics, Capricor Therapeutics, Appian, Yext, Agile Therapeutics, and Corbus Pharmaceuticals — New Research Emphasizes Economic Growth

GlobeNewswire December 27, 2018

Agile Therapeutics to Present at Biotech Showcase 2019

GlobeNewswire December 18, 2018

The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch

Benzinga.com  December 14, 2018

Agile Therapeutics, Inc. Meets With FDA on Comparative Wear Study of Twirla® and Xulane®

GlobeNewswire December 13, 2018

Agile Therapeutics Reports Third Quarter 2018 Financial Results

GlobeNewswire November 1, 2018

Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the 2018 North American Forum on Family Planning (NAFFP)

GlobeNewswire October 24, 2018

New Research Coverage Highlights MEDIFAST INC, Palo Alto Networks, Salesforce, Agile Therapeutics, Dicerna Pharmaceuticals, and Corbus Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire October 23, 2018

Thinking about buying stock in Agile Therapeutics, Advanced Micro Devices, Auris Medical Holding, Helios and Matheson Analytics Inc or Wells Fargo?

PR Newswire October 16, 2018

10 Hottest Stocks From October 15, 2018

Benzinga.com  October 15, 2018

46 Biggest Movers From Yesterday

Benzinga.com  October 10, 2018

10 Hottest Stocks From October 9, 2018

Benzinga.com  October 9, 2018

36 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  October 9, 2018

Mid-Day Market Update: Blackbaud Drops On Lowered FY18 Outlook; Agile Therapeutics Shares Surge

Benzinga.com  October 9, 2018

Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA

GlobeNewswire October 9, 2018

Agile Therapeutics Reports Second Quarter 2018 Financial Results

GlobeNewswire August 3, 2018

FDA’s Office of Drug Evaluation III Denies Agile Therapeutics, Inc.’s Initial Formal Dispute Resolution Request

GlobeNewswire July 24, 2018

Agile Therapeutics, Inc. Provides Corporate Update and Revised Cash Guidance

GlobeNewswire June 7, 2018